Chesnara has reported a sharp rise in first-half 2026 profitability, with operating capital generation up 79% to £96 million and adjusted operating profit rising 46% to £31 million, driven substantially by the completed acquisition of HSBC Life (UK), now rebranded Chesnara Life UK.
Cash remittances rose 31% to £73 million, while assets under administration climbed 38% to £21 billion from £15 billion. Own funds increased 14% to £976 million. The solvency coverage ratio fell to 185% from 257% at the end of 2025, reflecting the capital deployed to complete the HSBC Life acquisition, though the board noted this still sits five percentage points above the 180% proforma estimate given when the deal was announced.
The board declared a 6% increase in the interim dividend to 8.16p per share, in line with guidance given when the HSBC Life acquisition was first announced and representing what Chesnara described as a one-off additional step-up of 3% to the interim dividend specifically.
The dividend is due to be paid on 16 October 2026.
Group chief executive Steve Murray said Chesnara delivered a very strong financial performance in the first half of 2026, with operating capital generation up 79% and a 6% increase in the interim dividend. He said the integration of Chesnara Life UK, the group's largest acquisition to date, continues at pace with strong capital generation already delivered from the first five months of ownership. He also added that the regulatory change in control for the proposed acquisition of Scottish Widows Europe SA is anticipated around the end of 2026, with the group continuing to see attractive opportunities for growth underpinned by a healthy M&A pipeline and disciplined execution.
Analyst commentary following the results has been more precise about how much of the capital generation increase reflects genuinely recurring performance versus one-off deal benefits.
Panmure Liberum's Abid Hussain estimated that roughly £50 million of the £96 million total was a one-off benefit tied to the HSBC Life UK acquisition specifically, with around £10 million coming from diversification benefits that reduce the capital the enlarged group must hold, and a further £40 million from extending a mass lapse reinsurance arrangement and optimising a deferred tax programme. That leaves an estimated £45 million of recurring generation, which Hussain noted still covers the interim dividend 2.4 times over on the recurring elements alone.
Chesnara said it remains on track to generate £140 million of cash within the first five years of owning Chesnara Life UK, and that the business, together with the planned Scottish Widows Europe acquisition, is expected to contribute around £1 billion in lifetime cash flows once both deals are fully integrated. The Scottish Widows Europe transaction, announced in February 2026, is expected to add a further €250 million of lifetime cash generation and gives the group a base in Luxembourg.
Alongside the financial results, Chesnara reported operational progress on integrating its acquisitions. The company completed the Part VII transfer of the second Canada Life portfolio, with subsequent migration completed in early August.
On the HSBC Life UK integration specifically, Chesnara said it had completed the staff consultation required for its new UK target operating model, identified a combined UK leadership team, and completed the first planned transfer of employees to outsourcing provider SS&C, with full data migration from HSBC still scheduled for completion by the end of 2026.
Chesnara's results illustrate a common feature of acquisition-driven insurance results: headline growth figures that are real and board-confirmed, but that include a meaningful one-off component analysts are already separating out from the underlying run rate.
That distinction matters less for this half's dividend decision, which Chesnara had already signalled at the time of the HSBC Life announcement, and more for how the market should read future periods once the one-off capital release from that deal has worked through the numbers.
With Scottish Widows Europe still pending regulatory approval and full data migration not expected until year-end, the more informative test of Chesnara's underlying growth trajectory will likely come once both integrations are complete and the current one-off benefits have fully unwound.
